MARKET

CANF

CANF

Can-Fite BioPharma Ltd.
AMEX
3.400
-0.040
-1.16%
After Hours: 3.390 -0.01 -0.30% 19:21 05/22 EDT
OPEN
3.350
PREV CLOSE
3.440
HIGH
3.600
LOW
3.350
VOLUME
46.03K
TURNOVER
--
52 WEEK HIGH
23.40
52 WEEK LOW
2.830
MARKET CAP
7.28M
P/E (TTM)
-0.0019
1D
5D
1M
3M
1Y
5Y
1D
Can-Fite Announces Peer-Reviewed Publication Of Piclidenoson Data In Canine Osteoarthritis Study
NASDAQ · 6d ago
Can-Fite and Vetbiolix Gain Peer-Reviewed Validation for Piclidenoson in Canine Osteoarthritis
TipRanks · 6d ago
Can-Fite BioPharma Announces Publication Of Peer-Reviewed Scientific Article On Findings From Study Evaluating Piclidenoson For Treatment Of Canine Osteoarthritis
Benzinga · 6d ago
Can-Fite says Piclidenoson study shows mobility, pain improvements in canine osteoarthritis
PUBT · 6d ago
Weekly Report: what happened at CANF last week (0511-0515)?
Weekly Report · 6d ago
Scientific Publication of Can-Fite and Vetbiolix Validates Piclidenoson’s Potential in the Multi-Billion Dollar Canine Osteoarthritis Market
Barchart · 6d ago
Can-Fite Biopharma Raised to Buy From Hold by D. Boral Capital
Dow Jones · 05/13 21:24
Can-Fite Biopharma Price Target Announced at $7.00/Share by D. Boral Capital
Dow Jones · 05/13 21:24
More
About CANF
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

Webull offers Can Fite Biopharma Ltd stock information, including AMEX: CANF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CANF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CANF stock methods without spending real money on the virtual paper trading platform.